In vitro antimicrobial activity of MSI-78, a magainin analog

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1213-1216

  Fuchs, Peter C ^a,b   Barry, Arthur L ^a   Brown, Steven D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; MAGAININ DERIVATIVE; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PEXIGANAN ACETATE; PIPERACILLIN; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEROIDES FRAGILIS; CANDIDA ALBICANS; EGGERTHELLA LENTA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TOPICAL DRUG ADMINISTRATION; YEAST;

EID: 0031979410     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1213     Document Type: Article

References (11)

1. Hancock, R. E. W. 1997. Peptide antibiotics. Lancet 349:418-422.
2. Jacob, L., and M. Zasloff. 1994. Potential therapeutic application of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186:197-216.
3. Leyden, J. J., K. J. McGinley, C. A. Rowinski, A. E. Weber, and L. S. Jacob. 1993. In vivo antimicrobial activity of magainin topical cream against mixed skin flora, abstr. 474, p. 205. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. 3a. MacDonald, D. Personal communication.
5. MacDonald, D., L. Jones, and C. Messler. 1993. Comparison of topical agents magainin MSI-78 and mupirocin, potential for resistance development in Staphylococcus aureus, abstr. 1037, p. 309. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. MacDonald, D. L., A. Weber, H. Patterson, and L. Jacob. 1992. In vivo efficacy of a magainin compound, MSI-78, in a swine model of wound infection, abstr. 518, p. 197. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Maloy, W. L., and U. P. Kari. 1995. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37:105-122.
8. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard (M7-A4). National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. National Committee for Clinical Laboratory Standards. 1987. Methods for determining bactericidal activity of antimicrobial agents. Proposed guideline (M26-P). National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 3rd ed. Approved standard (M11-A3). National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard (M27-T). National Committee for Clinical Laboratory Standards, Wayne, Pa.